JMP Securities analyst Jason Butler weighs in on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after the biotech company reported second-quarter financial results that …
In light of Cytokinetics, Inc.’s (NASDAQ:CYTK) second-quarter update, JMP Securities analyst Jason Butler remains bullish for the biotech company’s pipeline drug-paved road ahead.
